185 related articles for article (PubMed ID: 33732206)
1. Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients.
Reyes-Leiva D; Alonso-Pérez J; Mayos M; Nuñez-Peralta C; Llauger J; Belmonte I; Pedrosa-Hernández I; Segovia S; Díaz-Manera J
Front Neurol; 2021; 12():621257. PubMed ID: 33732206
[No Abstract] [Full Text] [Related]
2. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
[TBL] [Abstract][Full Text] [Related]
3. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease.
Ruggeri P; Lo Monaco L; Musumeci O; Tavilla G; Gaeta M; Caramori G; Toscano A
Neurol Sci; 2020 Aug; 41(8):2175-2184. PubMed ID: 32162165
[TBL] [Abstract][Full Text] [Related]
5. The nature of respiratory muscle weakness in patients with late-onset Pompe disease.
Spiesshoefer J; Henke C; Kabitz HJ; Brix T; Görlich D; Herkenrath S; Randerath W; Young P; Boentert M
Neuromuscul Disord; 2019 Aug; 29(8):618-627. PubMed ID: 31327549
[TBL] [Abstract][Full Text] [Related]
6. Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests.
Nuñez-Peralta C; Montesinos P; Alonso-Jiménez A; Alonso-Pérez J; Reyes-Leiva D; Sánchez-González J; Llauger-Roselló J; Segovia S; Belmonte I; Pedrosa I; Martínez-Noguera A; Matellini-Mosca B; Walter G; Díaz-Manera J
Front Neurol; 2021; 12():634766. PubMed ID: 33796064
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.
Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
J Neurol; 2019 Jan; 266(1):133-147. PubMed ID: 30430231
[TBL] [Abstract][Full Text] [Related]
8. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
[TBL] [Abstract][Full Text] [Related]
9. Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease-an MRI study.
Vaeggemose M; Mencagli RA; Hansen JS; Dräger B; Ringgaard S; Vissing J; Andersen H
PeerJ; 2021; 9():e10928. PubMed ID: 33996274
[TBL] [Abstract][Full Text] [Related]
10. Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy.
Gruhn KM; Heyer CM; Güttsches AK; Rehmann R; Nicolas V; Schmidt-Wilcke T; Tegenthoff M; Vorgerd M; Kley RA
Mol Genet Metab Rep; 2015 Jun; 3():58-64. PubMed ID: 26937398
[TBL] [Abstract][Full Text] [Related]
11. Chest MRI to diagnose early diaphragmatic weakness in Pompe disease.
Harlaar L; Ciet P; van Tulder G; Pittaro A; van Kooten HA; van der Beek NAME; Brusse E; Wielopolski PA; de Bruijne M; van der Ploeg AT; Tiddens HAWM; van Doorn PA
Orphanet J Rare Dis; 2021 Jan; 16(1):21. PubMed ID: 33413525
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.
Gaeta M; Musumeci O; Mondello S; Ruggeri P; Montagnese F; Cucinotta M; Vinci S; Milardi D; Toscano A
Neuromuscul Disord; 2015 Nov; 25(11):852-8. PubMed ID: 26410244
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Muscle MRI in Patients with Neuromuscular Diseases-Association of Muscle Proton Density Fat Fraction with Semi-Quantitative Grading of Fatty Infiltration and Muscle Strength at the Thigh Region.
Schlaeger S; Sollmann N; Zoffl A; Becherucci EA; Weidlich D; Kottmaier E; Riederer I; Greve T; Montagnese F; Deschauer M; Schoser B; Zimmer C; Karampinos DC; Kirschke JS; Baum T
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201303
[TBL] [Abstract][Full Text] [Related]
14. Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up.
Ravaglia S; de Giuseppe R; Carlucci A; Jehne S; Crescimanno G; Ahmad L; Paoletti M; Clemente G; Pichiecchio A; Bazzano R; Cirio S; Valente EM; Danesino C; De Filippi P; Tartara A; Cena H
Front Cell Dev Biol; 2022; 10():793566. PubMed ID: 35252175
[No Abstract] [Full Text] [Related]
15. Skeletal muscle magnetic resonance imaging in Pompe disease.
Díaz-Manera J; Walter G; Straub V
Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
[TBL] [Abstract][Full Text] [Related]
16. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.
Figueroa-Bonaparte S; Segovia S; Llauger J; Belmonte I; Pedrosa I; Alejaldre A; Mayos M; Suárez-Cuartín G; Gallardo E; Illa I; Díaz-Manera J;
PLoS One; 2016; 11(10):e0163493. PubMed ID: 27711114
[TBL] [Abstract][Full Text] [Related]
18. Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT.
Fernández-Simón E; Carrasco-Rozas A; Gallardo E; González-Quereda L; Alonso-Pérez J; Belmonte I; Pedrosa-Hernández I; Montiel E; Segovia S; Suárez-Calvet X; Llauger J; Mayos M; Illa I; Barba-Romero MA; Barcena J; Paradas C; Carzorla MR; Creus C; Coll-Cantí J; Díaz M; Domínguez C; Fernández-Torrón R; García-Antelo MJ; Grau JM; López de Munáin A; Martínez-García FA; Morgado Y; Moreno A; Morís G; Muñoz-Blanco MA; Nascimento A; Parajuá-Pozo JL; Querol L; Rojas R; Robledo-Strauss A; Rojas-Marcos Í; Salazar JA; Usón M; Díaz-Manera J
Mol Genet Metab; 2019; 128(1-2):129-136. PubMed ID: 31378569
[TBL] [Abstract][Full Text] [Related]
19. Dynamic respiratory muscle function in late-onset Pompe disease.
Smith BK; Allen S; Mays S; Martin AD; Byrne BJ
Sci Rep; 2019 Dec; 9(1):19006. PubMed ID: 31831753
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography of abdominal muscles: Differential diagnosis of late-onset Pompe disease and myotonic dystrophy type 1.
Hsieh PC; Chang CW; Ro LS; Huang CC; Chi JE; Kuo HC
Front Neurol; 2022; 13():944464. PubMed ID: 36147041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]